• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法氏仓鼠模型的α-1 抗胰蛋白酶缺乏症会发展为肺部和肝脏疾病。

Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease.

机构信息

Department of Anatomy and Cell Biology.

Department of Radiology.

出版信息

JCI Insight. 2022 Mar 8;7(5):e143004. doi: 10.1172/jci.insight.143004.

DOI:10.1172/jci.insight.143004
PMID:35104244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8983124/
Abstract

Alpha-1 antitrypsin deficiency (AATD) is the most common genetic cause and risk factor for chronic obstructive pulmonary disease, but the field lacks a large-animal model that allows for longitudinal assessment of pulmonary function. We hypothesized that ferrets would model human AATD-related lung and hepatic disease. AAT-knockout (AAT-KO) and PiZZ (E342K, the most common mutation in humans) ferrets were generated and compared with matched controls using custom-designed flexiVent modules to perform pulmonary function tests, quantitative computed tomography (QCT), bronchoalveolar lavage (BAL) proteomics, and alveolar morphometry. Complete loss of AAT (AAT-KO) led to increased pulmonary compliance and expiratory airflow limitation, consistent with obstructive lung disease. QCT and morphometry confirmed emphysema and airspace enlargement, respectively. Pathway analysis of BAL proteomics data revealed inflammatory lung disease and impaired cellular migration. The PiZ mutation resulted in altered AAT protein folding in the liver, hepatic injury, and reduced plasma concentrations of AAT, and PiZZ ferrets developed obstructive lung disease. In summary, AAT-KO and PiZZ ferrets model the progressive obstructive pulmonary disease seen in AAT-deficient patients and may serve as a platform for preclinical testing of therapeutics including gene therapy.

摘要

α-1 抗胰蛋白酶缺乏症(AATD)是慢性阻塞性肺疾病最常见的遗传原因和危险因素,但该领域缺乏一种大型动物模型,无法对肺功能进行纵向评估。我们假设雪貂可以模拟人类 AATD 相关的肺和肝疾病。使用定制的 flexiVent 模块生成 AAT 敲除(AAT-KO)和 PiZZ(E342K,人类最常见的突变)雪貂,并与匹配的对照进行比较,以进行肺功能测试、定量计算机断层扫描(QCT)、支气管肺泡灌洗(BAL)蛋白质组学和肺泡形态计量学分析。AAT 的完全缺失(AAT-KO)导致肺顺应性增加和呼气气流受限,与阻塞性肺疾病一致。QCT 和形态计量学分别证实了肺气肿和气腔扩大。BAL 蛋白质组学数据分析的途径分析显示出炎症性肺病和细胞迁移受损。PiZ 突变导致肝脏中 AAT 蛋白折叠改变、肝损伤和 AAT 血浆浓度降低,PiZZ 雪貂发生阻塞性肺疾病。总之,AAT-KO 和 PiZZ 雪貂可模拟 AAT 缺乏患者中所见的进行性阻塞性肺疾病,并且可以作为包括基因治疗在内的治疗方法的临床前测试平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/e1ac9d8019cb/jciinsight-7-143004-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/6dbe7209bb84/jciinsight-7-143004-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/3c75d38459fe/jciinsight-7-143004-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/95abdb4ae67e/jciinsight-7-143004-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/9bd5b1d0676f/jciinsight-7-143004-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/04ebc6a47867/jciinsight-7-143004-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/a904ce8d875c/jciinsight-7-143004-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/02d75a3cd20a/jciinsight-7-143004-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/e1ac9d8019cb/jciinsight-7-143004-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/6dbe7209bb84/jciinsight-7-143004-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/3c75d38459fe/jciinsight-7-143004-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/95abdb4ae67e/jciinsight-7-143004-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/9bd5b1d0676f/jciinsight-7-143004-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/04ebc6a47867/jciinsight-7-143004-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/a904ce8d875c/jciinsight-7-143004-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/02d75a3cd20a/jciinsight-7-143004-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c4/8983124/e1ac9d8019cb/jciinsight-7-143004-g035.jpg

相似文献

1
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease.法氏仓鼠模型的α-1 抗胰蛋白酶缺乏症会发展为肺部和肝脏疾病。
JCI Insight. 2022 Mar 8;7(5):e143004. doi: 10.1172/jci.insight.143004.
2
Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.α1-抗胰蛋白酶缺乏症和慢性阻塞性肺疾病中肺气肿的独特和共有系统性生物标志物。
EBioMedicine. 2022 Oct;84:104262. doi: 10.1016/j.ebiom.2022.104262. Epub 2022 Sep 22.
3
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.肝靶向 RNA 干扰可在 ZZ 患者中提供稳定持久的α-1 抗胰蛋白酶水平降低。
J Hepatol. 2018 Aug;69(2):378-384. doi: 10.1016/j.jhep.2018.03.012. Epub 2018 Mar 21.
4
PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.PiSZ 型 α-1 抗胰蛋白酶缺乏症(AATD):与 PiZZ 型 AATD 和 PiMM COPD 相比的肺部表型和预后。
Thorax. 2015 Oct;70(10):939-45. doi: 10.1136/thoraxjnl-2015-206906. Epub 2015 Jul 3.
5
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.α-1-抗胰蛋白酶缺乏症:遗传变异、临床表现和治疗干预。
Mutat Res Rev Mutat Res. 2017 Jul;773:14-25. doi: 10.1016/j.mrrev.2017.03.001. Epub 2017 Mar 18.
6
An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.PiMM 和 PiZZ 个体的α2-巨球蛋白和α1-抗胰蛋白酶的血浆水平与 COPD 表型的关系。
Clin Biochem. 2024 Apr;126:110736. doi: 10.1016/j.clinbiochem.2024.110736. Epub 2024 Feb 29.
7
Pulmonary manifestations of alpha 1 antitrypsin deficiency.α1-抗胰蛋白酶缺乏症的肺部表现。
Am J Med Sci. 2024 Jul;368(1):1-8. doi: 10.1016/j.amjms.2024.04.002. Epub 2024 Apr 9.
8
Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency.α1-抗胰蛋白酶缺乏症所致肺气肿患者的支气管镜肺减容术。
Respiration. 2023;102(2):134-142. doi: 10.1159/000528182. Epub 2022 Dec 22.
9
Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).α1抗胰蛋白酶缺乏症(AATD)患者肺移植后肺气肿复发
Respir Med Case Rep. 2020 Nov 26;31:101309. doi: 10.1016/j.rmcr.2020.101309. eCollection 2020.
10
The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.初级保健提供者在α-1抗胰蛋白酶缺乏症检测中的重要作用。
Postgrad Med. 2017 Nov;129(8):889-895. doi: 10.1080/00325481.2017.1381539. Epub 2017 Oct 5.

引用本文的文献

1
Can Proteomics Play a Significant Role in the Identification of Biomarkers for Alpha1-Antitrypsin Deficiency?蛋白质组学能否在α1-抗胰蛋白酶缺乏症生物标志物的鉴定中发挥重要作用?
Int J Mol Sci. 2025 May 26;26(11):5085. doi: 10.3390/ijms26115085.
2
Ferret model of bleomycin-induced lung injury shares features of human idiopathic pulmonary fibrosis.博来霉素诱导的肺损伤雪貂模型具有人类特发性肺纤维化的特征。
bioRxiv. 2025 May 14:2025.05.08.652970. doi: 10.1101/2025.05.08.652970.
3
Dual SORT LNPs for multi-organ base editing.用于多器官碱基编辑的双SORT脂质纳米颗粒

本文引用的文献

1
A molecular cell atlas of the human lung from single-cell RNA sequencing.人类肺部单细胞 RNA 测序的分子细胞图谱。
Nature. 2020 Nov;587(7835):619-625. doi: 10.1038/s41586-020-2922-4. Epub 2020 Nov 18.
2
The structural basis for Z α-antitrypsin polymerization in the liver.肝脏中Zα-抗胰蛋白酶聚合的结构基础。
Sci Adv. 2020 Oct 21;6(43). doi: 10.1126/sciadv.abc1370. Print 2020 Oct.
3
Alpha-Antitrypsin Deficiency.α-抗胰蛋白酶缺乏症
Nat Biotechnol. 2025 Jun 2. doi: 10.1038/s41587-025-02675-z.
4
A single amino acid variant in the variable region I of AAV capsid confers liver detargeting.腺相关病毒衣壳可变区I中的单个氨基酸变体可实现肝脏脱靶。
bioRxiv. 2025 Jun 14:2025.03.04.641478. doi: 10.1101/2025.03.04.641478.
5
Spatial covariance reveals isothiocyanate natural products adjust redox stress to restore function in alpha-1-antitrypsin deficiency.空间协方差显示异硫氰酸酯天然产物可调节氧化还原应激以恢复α-1-抗胰蛋白酶缺乏症中的功能。
Cell Rep Med. 2025 Jan 21;6(1):101917. doi: 10.1016/j.xcrm.2024.101917. Epub 2025 Jan 13.
6
Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights.用于胰腺和肝脏疾病细胞及基因治疗临床前评估的靶向动物模型:监管与实践见解
Cytotherapy. 2025 Mar;27(3):259-278. doi: 10.1016/j.jcyt.2024.11.008. Epub 2024 Nov 19.
7
In utero and postnatal ivacaftor/lumacaftor therapy rescues multiorgan disease in CFTR-F508del ferrets.在体和产后 ivacaftor/lumacaftor 治疗可挽救 CFTR-F508del 雪貂的多器官疾病。
JCI Insight. 2024 Apr 22;9(8):e157229. doi: 10.1172/jci.insight.157229.
8
Durable transgene expression and efficient re-administration after rAAV2.5T-mediated fCFTRΔR gene delivery to adult ferret lungs.在通过rAAV2.5T介导的fCFTRΔR基因递送至成年雪貂肺后,实现了持久的转基因表达和有效的再次给药。
Mol Ther Methods Clin Dev. 2024 Mar 28;32(2):101244. doi: 10.1016/j.omtm.2024.101244. eCollection 2024 Jun 13.
9
Immunohistochemical detection of MUC5AC and MUC5B mucins in ferrets.免疫组化检测雪貂的 MUC5AC 和 MUC5B 粘蛋白。
BMC Res Notes. 2023 Jun 22;16(1):111. doi: 10.1186/s13104-023-06388-x.
10
Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle Peptides.通过具有两亲性穿梭肽递呈的 CRISPR/Nuclease 对雪貂呼吸道上皮细胞进行基因组编辑。
Hum Gene Ther. 2023 Aug;34(15-16):705-718. doi: 10.1089/hum.2023.016. Epub 2023 Jul 20.
N Engl J Med. 2020 Apr 9;382(15):1443-1455. doi: 10.1056/NEJMra1910234.
4
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病临床进展
N Engl J Med. 2019 Sep 26;381(13):1257-1266. doi: 10.1056/NEJMra1900500.
5
Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病发病机制的最新进展
N Engl J Med. 2019 Sep 26;381(13):1248-1256. doi: 10.1056/NEJMra1900475.
6
Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.FEV1:FVC 阈值对 COPD 相关住院和死亡的鉴别准确性。
JAMA. 2019 Jun 25;321(24):2438-2447. doi: 10.1001/jama.2019.7233.
7
A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.糖聚合物改善异常囊性纤维化黏液的黏弹性和纤毛传输功能。
JCI Insight. 2019 Apr 18;4(8). doi: 10.1172/jci.insight.125954.
8
In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis.VX-770 在子宫内和产后给药可挽救雪貂囊性纤维化模型中的多器官疾病。
Sci Transl Med. 2019 Mar 27;11(485). doi: 10.1126/scitranslmed.aau7531.
9
Highly Efficient Transgenesis in Ferrets Using CRISPR/Cas9-Mediated Homology-Independent Insertion at the ROSA26 Locus.利用 CRISPR/Cas9 介导的同源非依赖性插入 ROSA26 基因座在雪貂中进行高效转基因。
Sci Rep. 2019 Feb 13;9(1):1971. doi: 10.1038/s41598-018-37192-4.
10
Editing out five paralogs to create a mouse model of genetic emphysema.编辑掉五个基因家族同源物以构建遗传肺气肿的小鼠模型。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2788-2793. doi: 10.1073/pnas.1713689115. Epub 2018 Feb 16.